This present study aims to investigate the effectiveness and cost-effectiveness of a high intensity exercise program, a low-to-moderate intensity exercise program and a waiting list control group on physical fitness (cardiorespiratory fitness and…
ID
Source
Brief title
Condition
- Breast neoplasms malignant and unspecified (incl nipple)
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Cardiorespiratory fitness, muscle strength and fatigue.
Secondary outcome
Secondary outcome variables include body composition and bone mineral density,
health-related quality of life, physical activity
level, satisfaction with the intervention, mood disturbances, sleep quality,
functioning in daily life and return to work.
Background summary
Cancer chemotherapy is frequently associated with a decline in general physical
fitness and severe symptoms of fatigue. While accumulating evidence suggests
that physical activity and exercise interventions after chemotherapy may
contribute to preservation of physical fitness and reduction of fatigue.
However, evidence-based recommendations regarding the optimal training approach
and training intensity in cancer patients are still lacking.
Study objective
This present study aims to investigate the effectiveness and cost-effectiveness
of a high intensity exercise program, a low-to-moderate intensity exercise
program and a waiting list control group on physical fitness (cardiorespiratory
fitness and muscle strength) and fatigue in cancer patients who completed
chemotherapy.
Study design
This multicenter, prospective, randomized trial will compare two exercise
programs and a waiting list contole group.
Intervention
A. High intensity exercise program
Patients allocated to the high intensity exercise program will train in groups
twice a week for 12 weeks under supervision of a physiotherapist. One training
session takes one hour. The high intensity exercise program includes high
intensity endurance and resistance exercises. In addition, daily physical
activity is stimulated using behavioural motivational techniques.
B. Low-to-moderate intensity exercise program
Patients allocated to the low-to-moderate intensity exercise program will train
in groups twice a week, for 12 weeks under supervision of a physiotherapist as
well. One training session takes one hour. The low-to-moderate exercise program
includes the same endurance and resistance exercises compared to the high
intensity exercise program, but differs in training intensity. In addition,
daily physical activity is stimulated using behavioural motivational
techniques.
Study burden and risks
In total, 280 consenting patients will be randomly assigned to either a 12-week
high intensity exercise program or a low-to-moderate intensity exercise
program. Next, patients from both groups will be randomly assigned to immediate
training or waiting list (i.e. waiting list control group). After 12 weeks,
patients of the waiting list control group will start with the exercise program
they have been allocated to.
Both exercise programs, the high intensity exercise program and the
low-to-moderate intensity exercise program, consist of 12 weeks of training,
twice a week (24 h.). Furthermore behavioural motivational counselling sessions
(3 h.) will be provided during and after the exercise programs to stimulate
daily physical activity.
All patients participating in the randomized trial will be asked 3 times to
undergo a physical fitness examination (1.15 h.) and to complete self-report
questionnaires (60 min.), 4-6 weeks after chemotherapy, after completion of the
exercise program and after 12 months follow-up. In addition, all patients will
be invited for a DXA scan two times (30 min.) and will be asked to complete a
cost diary every three months (30 min.).
Relevance: If demonstrated to be effective, the availability of such exercise
intervention programs will be a welcome addition to the standard program of
care offered to cancer patients after chemotherapy treatment.
Van der Boechorststraat 7
Amsterdam 1081 BT
NL
Van der Boechorststraat 7
Amsterdam 1081 BT
NL
Listed location countries
Age
Inclusion criteria
Patients with histological confirmed primary breast, colon, ovarian, cervix, testis cancer or lymphomas with no indication of recurrent or progressive disease, who completed ((neo)adjuvant) chemotherapy with curative intention, are eligible for this study.
Exclusion criteria
Patients who are not able to perform basic activities such as walking or biking, who show cognitive disorders or severe emotional instability, who are suffering from other disabling comorbidity that might hamper physical performance capacity ( e.g. heart failure, chronic obstructive pulmonary disease (COPD), orthopaedic conditions and neurological disorders), and patients who are unable to understand and read the Dutch language will be excluded from the study.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL32880.015.10 |